FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2077366276> ?p ?o ?g. }

• W2077366276 endingPage "2247" @default.
• W2077366276 startingPage "2240" @default.
• W2077366276 abstract "The purine analogs pentostatin and cladribine have revolutionized the treatment of hairy cell leukemia (HCL) with overall responses in greater than 85% of patients and a median progression-free survival of up to 15 years. They continue to be effective at second- and even third-line therapy; however, alternative treatments are needed for patients who are or have become refractory to these agents or whose remissions are shorter with each course of therapy.The authors conducted a retrospective review of 8 patients who received pentostatin or cladribine combined concurrently (n = 6 patients) or sequentially (n = 2 patients) with rituximab at second-line therapy (n = 3 patients) and at subsequent lines of therapy (n = 5 patients). Results from a previously reported database of 219 patients with HCL (73 patients who received second-line therapy and 20 patients who received third-line therapy) were used as a historic control group against which to measure benefit.All 8 patients responded to therapy, with 7 complete responses (CRs) (87.5%) and minimal toxicity. All patients who had CRs were negative for minimal residual disease (MRD). At a median follow-up of 29 months (range, 5-39 months) 1 patient developed recurrent disease, and the estimated 2-year recurrence rate was 20% (0% after second-line therapy and 25% after subsequent lines of therapy). In the historic control group, the CR rates were 70% after second-line therapy and 45% after third-line therapy, and the recurrence rates at 2 years were 15% and 33%, respectively.The combination of purine analogs with rituximab was safe and effective for patients with recurrent and/or refractory HCL, and the current results suggested an added benefit compared with standard treatment." @default.
• W2077366276 created "2016-06-24" @default.
• W2077366276 creator A5034415866 @default.
• W2077366276 creator A5051208373 @default.
• W2077366276 creator A5051974926 @default.
• W2077366276 creator A5057640205 @default.
• W2077366276 creator A5059536209 @default.
• W2077366276 creator A5078295579 @default.
• W2077366276 creator A5078732174 @default.
• W2077366276 creator A5086268455 @default.
• W2077366276 creator A5090012595 @default.
• W2077366276 date "2007-09-20" @default.
• W2077366276 modified "2023-10-12" @default.
• W2077366276 title "The role of rituximab in combination with pentostatin or cladribine for the treatment of recurrent/refractory hairy cell leukemia" @default.
• W2077366276 cites W129142841 @default.
• W2077366276 cites W1840700258 @default.
• W2077366276 cites W1963776928 @default.
• W2077366276 cites W1972244910 @default.
• W2077366276 cites W1988217711 @default.
• W2077366276 cites W1991758119 @default.
• W2077366276 cites W1995570857 @default.
• W2077366276 cites W1998578585 @default.
• W2077366276 cites W2002246616 @default.
• W2077366276 cites W2008060191 @default.
• W2077366276 cites W2012048337 @default.
• W2077366276 cites W2015292502 @default.
• W2077366276 cites W2020094108 @default.
• W2077366276 cites W2023435505 @default.
• W2077366276 cites W2024961933 @default.
• W2077366276 cites W2025498393 @default.
• W2077366276 cites W2047918572 @default.
• W2077366276 cites W2053584187 @default.
• W2077366276 cites W2077649997 @default.
• W2077366276 cites W2078641935 @default.
• W2077366276 cites W2088299237 @default.
• W2077366276 cites W2095259773 @default.
• W2077366276 cites W2103140628 @default.
• W2077366276 cites W2104501243 @default.
• W2077366276 cites W2107567250 @default.
• W2077366276 cites W2112628345 @default.
• W2077366276 cites W2120218252 @default.
• W2077366276 cites W2132433919 @default.
• W2077366276 cites W2142998407 @default.
• W2077366276 cites W2147256400 @default.
• W2077366276 cites W2148833212 @default.
• W2077366276 cites W2157872184 @default.
• W2077366276 cites W2168348993 @default.
• W2077366276 cites W2168926834 @default.
• W2077366276 cites W2255194647 @default.
• W2077366276 cites W2275948481 @default.
• W2077366276 cites W2335889607 @default.
• W2077366276 cites W238066860 @default.
• W2077366276 cites W4256521151 @default.
• W2077366276 cites W78071506 @default.
• W2077366276 doi "https://doi.org/10.1002/cncr.23032" @default.
• W2077366276 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17886250" @default.
• W2077366276 hasPublicationYear "2007" @default.
• W2077366276 type Work @default.
• W2077366276 sameAs 2077366276 @default.
• W2077366276 citedByCount "50" @default.
• W2077366276 countsByYear W20773662762012 @default.
• W2077366276 countsByYear W20773662762013 @default.
• W2077366276 countsByYear W20773662762014 @default.
• W2077366276 countsByYear W20773662762015 @default.
• W2077366276 countsByYear W20773662762016 @default.
• W2077366276 countsByYear W20773662762017 @default.
• W2077366276 countsByYear W20773662762020 @default.
• W2077366276 countsByYear W20773662762023 @default.
• W2077366276 crossrefType "journal-article" @default.
• W2077366276 hasAuthorship W2077366276A5034415866 @default.
• W2077366276 hasAuthorship W2077366276A5051208373 @default.
• W2077366276 hasAuthorship W2077366276A5051974926 @default.
• W2077366276 hasAuthorship W2077366276A5057640205 @default.
• W2077366276 hasAuthorship W2077366276A5059536209 @default.
• W2077366276 hasAuthorship W2077366276A5078295579 @default.
• W2077366276 hasAuthorship W2077366276A5078732174 @default.
• W2077366276 hasAuthorship W2077366276A5086268455 @default.
• W2077366276 hasAuthorship W2077366276A5090012595 @default.
• W2077366276 hasBestOaLocation W20773662761 @default.
• W2077366276 hasConcept C109246011 @default.
• W2077366276 hasConcept C121332964 @default.
• W2077366276 hasConcept C126322002 @default.
• W2077366276 hasConcept C141071460 @default.
• W2077366276 hasConcept C142424586 @default.
• W2077366276 hasConcept C181199279 @default.
• W2077366276 hasConcept C185592680 @default.
• W2077366276 hasConcept C2775952470 @default.
• W2077366276 hasConcept C2776476023 @default.
• W2077366276 hasConcept C2776694085 @default.
• W2077366276 hasConcept C2776999253 @default.
• W2077366276 hasConcept C2777063308 @default.
• W2077366276 hasConcept C2778461978 @default.
• W2077366276 hasConcept C2779200787 @default.
• W2077366276 hasConcept C2779338263 @default.
• W2077366276 hasConcept C2780483514 @default.
• W2077366276 hasConcept C2780653079 @default.
• W2077366276 hasConcept C2780775027 @default.
• W2077366276 hasConcept C29730261 @default.

• next